neuropeptide Y5 antagonists (Actelion)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameneuropeptide Y5 antagonists (Actelion)
Drug Alias Nameneuropeptide Y5 antagonists (Axovan)obesity therapeutics (Axovan)Axovan-3obesity therapeutics (Actelion)AX-81 +[6] 
ClassificationSmall molecules
Mechanisms of ActionNeuropeptide Y receptor type 5 antagonistsAppetite suppressant
TargetsNeuropeptide Y receptor type 5
Therapy Area/IndicationsFeeding and Eating DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAxovan AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxovan AGActelion Ltd
Active IndicationsN/A
Inactive IndicationsFeeding and Eating DisordersObesity

Other Information

ATC CodeN/A
Related LinksN/A